India to Philippines: Heparin Export Trade Route
India has recorded 206 verified shipments of Heparin exported to Philippines, representing a combined trade value of $14.4M USD. This corridor is served by 19 active Indian exporters, with an average shipment value of $70.1K USD. The leading Indian exporter is SAKAR HEALTHCARE LIMITED, which accounts for 48% of total export value with 62 shipments worth $7.0M USD. On the buying side, NA is the largest importer in Philippines with $3.8M USD in purchases. The top 3 suppliers — SAKAR HEALTHCARE LIMITED, SAKAR HEALTHCARE LIMITED , TROIKAA PHARMACEUTICALS LIMITED — together control 71% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Heparin corridor is one of India's established pharmaceutical export routes, with 206 shipments documented worth a combined $14.4M USD. The route is dominated by SAKAR HEALTHCARE LIMITED, which alone accounts for roughly 48% of all export value, reflecting the consolidated nature of India's heparin manufacturing sector.
Across 19 active suppliers, the average shipment value stands at $70.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during July–September, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 26.7%, placing it at rank #17 among India's top heparin export destinations globally.
On the import side, key buyers of Indian heparin in Philippines include NA, TO THE ORDER OF SECURITY BANK CORPO, TO THE ORDER OF ASIA UNITED BANK CO and 38 others. NA is the single largest importer with 36 shipments valued at $3.8M USD.
Route Characteristics
- Average transit
